CD19 and rheumatoid arthritis: Although further studies still need to be done on FoxP3+ B cells, Guo et al., (2015) also compared their frequency with TGF-β CD19+ B cells and found no significant difference among the expression frequencies of these groups in both healthy and RA groups [10].